NO780359L - Nye ergolinderivater. - Google Patents
Nye ergolinderivater.Info
- Publication number
- NO780359L NO780359L NO780359A NO780359A NO780359L NO 780359 L NO780359 L NO 780359L NO 780359 A NO780359 A NO 780359A NO 780359 A NO780359 A NO 780359A NO 780359 L NO780359 L NO 780359L
- Authority
- NO
- Norway
- Prior art keywords
- ergoline
- derivative according
- methoxy
- och3
- ergoline derivative
- Prior art date
Links
- AWFDCTXCTHGORH-HGHGUNKESA-N 6-[4-[(6ar,9r,10ar)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carbonyl]piperazin-1-yl]-1-methylpyridin-2-one Chemical class O=C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC(Br)=C(C=34)C2)C1)C)N(CC1)CCN1C1=CC=CC(=O)N1C AWFDCTXCTHGORH-HGHGUNKESA-N 0.000 claims description 23
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 6
- 239000000010 aprotic solvent Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 239000000460 chlorine Substances 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- -1 hydroxy, methoxy Chemical group 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 229940025084 amphetamine Drugs 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- YQQSRZSUGBETRS-UHFFFAOYSA-N 1h-pyridazine-6-thione Chemical compound SC1=CC=CN=N1 YQQSRZSUGBETRS-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- DTXVKPOKPFWSFF-UHFFFAOYSA-N 3(S)-hydroxy-13-cis-eicosenoyl-CoA Chemical compound NC1=CC=C(Cl)N=N1 DTXVKPOKPFWSFF-UHFFFAOYSA-N 0.000 description 1
- ABQHEWLZYZQXHY-UHFFFAOYSA-N 3-chloro-1h-pyridazine-6-thione Chemical compound SC1=CC=C(Cl)N=N1 ABQHEWLZYZQXHY-UHFFFAOYSA-N 0.000 description 1
- NWUYAYVDHURYQU-UHFFFAOYSA-N 3-methoxy-1h-pyridazine-6-thione Chemical compound COC1=CC=C(S)N=N1 NWUYAYVDHURYQU-UHFFFAOYSA-N 0.000 description 1
- YPWBPONDYDVMLX-UHFFFAOYSA-N 6-methoxypyridazin-3-amine Chemical compound COC1=CC=C(N)N=N1 YPWBPONDYDVMLX-UHFFFAOYSA-N 0.000 description 1
- SRYILVFXQKHDGZ-UHFFFAOYSA-N 6-sulfanylidene-1,2-dihydropyridazin-3-one Chemical compound OC1=CC=C(S)N=N1 SRYILVFXQKHDGZ-UHFFFAOYSA-N 0.000 description 1
- 241000220479 Acacia Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229940008238 amphetamine sulfate Drugs 0.000 description 1
- PYHRZPFZZDCOPH-UHFFFAOYSA-N amphetamine sulfate Chemical compound OS(O)(=O)=O.CC(N)CC1=CC=CC=C1.CC(N)CC1=CC=CC=C1 PYHRZPFZZDCOPH-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- LETVJWLLIMJADE-UHFFFAOYSA-N pyridazin-3-amine Chemical compound NC1=CC=CN=N1 LETVJWLLIMJADE-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4302/77A GB1555751A (en) | 1977-02-02 | 1977-02-02 | Ergoline deritatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO780359L true NO780359L (no) | 1978-08-03 |
Family
ID=9774609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO780359A NO780359L (no) | 1977-02-02 | 1978-02-01 | Nye ergolinderivater. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US4166911A (fi) |
| AT (1) | AT356294B (fi) |
| BE (1) | BE863020A (fi) |
| DE (1) | DE2803255A1 (fi) |
| DK (1) | DK47478A (fi) |
| FI (1) | FI780269A (fi) |
| FR (1) | FR2379535A1 (fi) |
| GB (1) | GB1555751A (fi) |
| IE (1) | IE46321B1 (fi) |
| NL (1) | NL7801198A (fi) |
| NO (1) | NO780359L (fi) |
| NZ (1) | NZ186233A (fi) |
| SE (1) | SE7801187L (fi) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2640223A (en) * | 1948-06-08 | 1953-06-02 | Hubert B Secor | Oyster preparing machine |
| AU526764B2 (en) * | 1978-09-08 | 1983-01-27 | Farmitalia Carlo Erba S.P.A. | Ergoline derivatives |
| AU553809B2 (en) * | 1981-07-21 | 1986-07-31 | Farmitalia Carlo Erba S.P.A. | Ergoline derivatives |
| CH653333A5 (de) * | 1981-11-04 | 1985-12-31 | Sandoz Ag | N-substituierte ergolin- und 9,10-didehydroergolinderivate, ihre herstellung und sie enthaltende arzneimittel. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1249014B (de) * | 1965-05-14 | 1967-08-31 | Robert Bosch Gmbh, Stuttgart | Kraftstoffemspntzpumpe fur Brennkraftmaschinen |
| US3642792A (en) * | 1968-02-26 | 1972-02-15 | Lepetit Spa | Pyridazine derivatives |
| US3598822A (en) * | 1969-01-21 | 1971-08-10 | Sandoz Ag | 3-substituted amino-6-hydrazino pyridazines |
| US3687971A (en) * | 1970-06-22 | 1972-08-29 | Merck & Co Inc | 4-(pyrrolyl)-salicylic acid derivatives |
| US3975388A (en) * | 1971-02-22 | 1976-08-17 | Bdh Pharmaceuticals Limited | Pyridazinones |
| GB1324579A (en) * | 1971-05-29 | 1973-07-25 | Isf Spa | N-substituted 3-aminoalkoxy-6-hydrazinopyridazines having antihypertensive activity and their preparation |
| US3856799A (en) * | 1971-08-05 | 1974-12-24 | Squibb & Sons Inc | Intermediates for production of amino derivatives of pyrazolopyridine carboxylic acids and esters |
| US3957785A (en) * | 1971-12-02 | 1976-05-18 | Societa' Farmaceutici Italia S.P.A. | Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives |
| IE41533B1 (en) * | 1974-03-14 | 1980-01-30 | Sandoz Ltd | Thiomethyl ergolene derivatives |
| US3957805A (en) * | 1974-07-24 | 1976-05-18 | American Cyanamid Company | Substituted pyridines and diazines and methods of preparing the same |
-
1977
- 1977-02-02 GB GB4302/77A patent/GB1555751A/en not_active Expired
-
1978
- 1978-01-13 FR FR7800896A patent/FR2379535A1/fr active Granted
- 1978-01-16 NZ NZ186233A patent/NZ186233A/xx unknown
- 1978-01-17 US US05/870,095 patent/US4166911A/en not_active Expired - Lifetime
- 1978-01-18 BE BE184403A patent/BE863020A/xx unknown
- 1978-01-26 DE DE19782803255 patent/DE2803255A1/de not_active Withdrawn
- 1978-01-27 FI FI780269A patent/FI780269A/fi not_active Application Discontinuation
- 1978-01-30 IE IE199/78A patent/IE46321B1/en unknown
- 1978-01-31 AT AT65878A patent/AT356294B/de not_active IP Right Cessation
- 1978-02-01 DK DK47478A patent/DK47478A/da unknown
- 1978-02-01 NO NO780359A patent/NO780359L/no unknown
- 1978-02-01 SE SE7801187A patent/SE7801187L/xx unknown
- 1978-02-02 NL NL7801198A patent/NL7801198A/xx not_active Application Discontinuation
-
1979
- 1979-03-19 US US06/021,671 patent/US4252948A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FR2379535B1 (fi) | 1981-02-20 |
| FR2379535A1 (fr) | 1978-09-01 |
| NL7801198A (nl) | 1978-08-04 |
| AT356294B (de) | 1980-04-25 |
| US4166911A (en) | 1979-09-04 |
| SE7801187L (sv) | 1978-08-03 |
| DK47478A (da) | 1978-08-03 |
| NZ186233A (en) | 1979-07-11 |
| DE2803255A1 (de) | 1978-08-03 |
| BE863020A (fr) | 1978-07-18 |
| US4252948A (en) | 1981-02-24 |
| IE780199L (en) | 1978-08-02 |
| FI780269A (fi) | 1978-08-03 |
| ATA65878A (de) | 1979-09-15 |
| GB1555751A (en) | 1979-11-14 |
| IE46321B1 (en) | 1983-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4031098A (en) | Camptothecin analogues | |
| US4330559A (en) | Method of treating benign prostatic hypertrophy | |
| NO155490B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 4-)1"-hydroksy-2"-(n-imidazolyl)etyl)bibenzyl. | |
| NO780359L (no) | Nye ergolinderivater. | |
| US3872091A (en) | New 2{62 , 16{62 -diamino-androstanes and their preparation | |
| GB1569251A (en) | Pyridobenzodiazepines | |
| GB1568398A (en) | Triazolo pyridazine derivatives | |
| US4927837A (en) | Derivatives of 3-piperidine carbaldehyde oxime and their use as medicaments | |
| SU852176A3 (ru) | Способ получени производных стероид-СпиРО-ОКСАзОлидиНОНА | |
| JPS5946235B2 (ja) | シンキエルゴリンユウドウタイノ セイホウ | |
| US3478028A (en) | 4-substituted-1-hydroxylaminophthalazines | |
| CA1076577A (en) | Process for preparing hydrazinopyridazine derivatives | |
| EP0159112A1 (en) | Process for the preparation of diaminopyridines | |
| US3563998A (en) | 2 - (4 - (2',6' - diphenyl - 4 - pyridyl)phenoxy)-and 2 - (4 - (4',6' - diphenyl - 2 -pyridyl)phenoxy) lower aliphatic monocarbocylic acids and esters | |
| US4478841A (en) | 3-[2-(Tetra- and Hexa- hydro-4-pyridyl)-ethyl]-indoles and their use as medicaments | |
| US4614824A (en) | Novel apovincaminic acid derivatives | |
| NO158737B (no) | Analogifremgangsmaate til fremstilling av nye 3-alkoksy-6-alkylidenhydrazinpyridaziner. | |
| US3562255A (en) | 17-propargylamines of steroidal dithioketals | |
| US4117133A (en) | Vasodilating cuanzine hydrazides | |
| US4338320A (en) | Esters of 6'-hydroxycinchonine, and a method of treating arrythmia with them | |
| CS198157B2 (en) | Process for preparing 2-hydroxymethyl-3-hydoxy-6-/1-hydroxy-2-terc.butylaminoethyl/pyridine and additive salt with acid thereof | |
| US3466290A (en) | 9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2-b)thiophene ethers | |
| US4148898A (en) | N-oxy-ajmaline and the use thereof in treating cardiovascular disorders | |
| US3318897A (en) | Novel method for preparing yohimbinone | |
| US3054802A (en) | Podophyllic acid hydrazides |